Transductin-1 and transductin-2 and applications to hereditary deafness

Details for Australian Patent Application No. 2004200813 (hide)

Owner The Government of the United States of America as represented by the Secretary, Department of Health and Human Services

Inventors Friedman, Thomas; Wilcox, Edward; Kurima, Kiyoto; Griffith, Andrew J.

Agent Fisher Adams Kelly

Pub. Number AU-A-2004200813

Filing date 2 March 2004

Wipo publication date 22 September 2005

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

A61K 031/7088 - Compounds having three or more nucleosides or nucleotides

C07K 014/075 Peptides having more than 20 amino acids

Event Publications

18 March 2004 Complete Application Filed

22 September 2005 Application Open to Public Inspection

  Published as AU-A-2004200813

30 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200814-A sample distribution apparatus/system

2004200812-Authoring system and method